Use of Complementary and Integrative Medicine Among Patients With Glioblastoma Multiforme Seen at a Tertiary Care Center

por Munoz-Casabella, Amanda, Wahner-Roedler, Dietlind L., Croghan, Ivana T., Petterson, Tanya M., Fuehrer, Debbie L., Bauer, Brent A.
Publicado 2022

DDRE-12. HETEROGENOUS RESPONSE OF IDH-MUTANT AND IDH-WT GLIOMA TO NAMPT INHIBITION

por Rahman, Masum, Hirte, Renee, Olson, Ian, Mansour, Moustafa, Ikram, Samar, MunozCasabella, Amanda, Sutiwisesak, Rujapope, Carlstrom, Lucas, Warrington, Arthur, Rajani, Karishma, Sarkaria, Jann, Burns, Terry
Publicado 2021

Sulfonylurea Receptor 1 in Central Nervous System Injury: An Updated Review

por Jha, Ruchira M., Rani, Anupama, Desai, Shashvat M., Raikwar, Sudhanshu, Mihaljevic, Sandra, Munoz-Casabella, Amanda, Kochanek, Patrick M., Catapano, Joshua, Winkler, Ethan, Citerio, Giuseppe, Hemphill, J. Claude, Kimberly, W. Taylor, Narayan, Raj, Sahuquillo, Juan, Sheth, Kevin N., Simard, J. Marc
Publicado 2021

Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas

por Riviere-Cazaux, Cecile, Lacey, Jean M, Carlstrom, Lucas P, Laxen, William J, Munoz-Casabella, Amanda, Hoplin, Matthew D, Ikram, Samar, Zubair, Abdullah Bin, Andersen, Katherine M, Warrington, Arthur E, Decker, Paul A, Kaufmann, Timothy J, Campian, Jian L, Eckel-Passow, Jeanette E, Kizilbash, Sani H, Tortorelli, Silvia, Burns, Terry C
Publicado 2023

Blood-brain barrier disruption defines the extracellular metabolome of live human high-grade gliomas

por Riviere-Cazaux, Cecile, Carlstrom, Lucas P., Rajani, Karishma, Munoz-Casabella, Amanda, Rahman, Masum, Gharibi-Loron, Ali, Brown, Desmond A., Miller, Kai J., White, Jaclyn J., Himes, Benjamin T., Jusue-Torres, Ignacio, Ikram, Samar, Ransom, Seth C., Hirte, Renee, Oh, Ju-Hee, Elmquist, William F., Sarkaria, Jann N., Vaubel, Rachael A., Rodriguez, Moses, Warrington, Arthur E., Kizilbash, Sani H., Burns, Terry C.
Publicado 2023